2,814 results on '"Lip, G."'
Search Results
2. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
3. Risk of death and thromboembolic events in patients with supraventricular arrhythmias admitted to the emergency department
4. Clinical impact of renal function changes in patients with atrial fibrillation receiving anticoagulation with marginal renal function
5. Development and validation of a machine learning-based prediction model for sudden cardiac death in the general population: insights from the community cardiovascular cohort
6. Phenotypes and outcomes in patients with atrial fibrillation: a global unsupervised cluster analysis from Phase II/III of the GLORIA-AF registry
7. Early rhythm control in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III
8. Impact of environment and ethnicity on prognosis in AF patients: does the 'where' matter more than the 'who'?
9. Risk of death, thrombotic and hemorrhagic events in patients with atrial fibrillation and systemic autoimmune diseases
10. Cost-effectiveness of atrial fibrillation detection with insertable cardiac monitors in large-artery or small-vessel disease stroke in the United Kingdom
11. Non-alcoholic fatty liver disease in patients with atrial fibrillation: a report from a global federated health network
12. Time-trends of sex differences in stroke risk in atrial fibrillation: Are female patients still at higher risk today? A nationwide cohort study
13. Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry
14. Atrial fibrillation accelerates functional decline in older adults: a 15-year follow-up population-based study
15. Phenotypes and outcomes in non-anticoagulated patients with atrial fibrillation: An unsupervised cluster analysis
16. Social determinants of health and clinical outcomes among patients with atrial fibrillation: evidence from a global federated health research network.
17. C-reactive protein in Stroke-Heart-Syndrome: a propensity-matched analysis of a global federated health network
18. Impact of integrated care in patients with heart failure with reduced ejection fraction: a report from the WARCEF trial
19. Risks of cardiovascular events after acute ischemic stroke and intra-cranial hemorrhage
20. Risk differences between atrial fibrillation patients with different clinical phenotypes: insights from the French population
21. The relationship between changes of antithrombotic drug regimen after ischemic stroke and risks of clinical outcomes in patients with atrial fibrillation
22. Clinical impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study
23. Comparison of early rhythm control strategies in patients with atrial fibrillation: a nationwide population-based cohort study
24. Role of liver disease in management and outcomes of european and asian patients with atrial fibrillation: a report from two regional prospective observational AF registries
25. The impact of aging and atrial fibrillation on thrombus formation in-silico
26. ABC (Atrial fibrillation Better Care) pathway in asian patients: an analysis from the prospective Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry
27. The effect of a mobile health technology integrated care across multimorbidity patterns in atrial fibrillation patients: a latent-class ancillary analysis from the mAFA-II randomised clinical trial
28. New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase 4 inhibitors: A Chinese population-based cohort study
29. Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia
30. Comparative analysis of oral anticoagulation therapy in Asian patients with atrial fibrillation and end-stage renal disease: a nationwide population-based cohort study
31. Short and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation
32. Comorbidity patterns and health-related outcomes in older adults with atrial fibrillation: nationwide population-based findings from swedish national patient register
33. The risk and cause of death according to prevalent atrial fibrillation and the role of CHA2DS2-VASc score to stratify the risk of all-cause and cardiovascular death
34. Incidence of conduction disturbances in patients with diabetes mellitus: a comparison with age- and sex matched controls from a nationwide observational study
35. Oral anticoagulant use and outcomes in Asian patients with atrial fibrillation in the GLORIA-AF Registry
36. Educational level and risk of all-cause death in patients with heart failure with reduced ejection fraction (HFrEF): a report from the WARCEF Trial
37. Arterial stiffness assessment in patients with resistant hypertension using pulse wave analysis
38. The association between HbA1c variability and strokes in patients receiving anticoagulants
39. Screening for atrial fibrillation by village doctors in rural areas of china: the jiangsu province rural community atrial fibrillation project
40. Effects of SGLT2i on reducing risks of cardiovascular events and dementia in atrial fibrillation patients with diabetes mellitus: a nationwide cohort study
41. Relationship of clinical complexity domains to management and outcomes of european and asian patients with atrial fibrillation: a comparison of two regional prospective observational AF registries
42. Risk of major cardiovascular events and bleeding in atrial fibrillation patients with chronic obstructive pulmonary disease treated with low dose azithromycin prophylaxis
43. Dementia risk among patients with atrial fibrillation treated with non-vitamin K vs. vitamin-K oral anticoagulants
44. Adverse outcomes according to metabolic status in obese and overweight patients with atrial fibrillation: a report from the GLORIA-AF Phase II and III Registry
45. Association between brachial-ankle pulse wave velocity and new-onset atrial fibrillation: A report from Kailuan Study
46. Epidemiology and clinical impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: findings from an european prospective observational registry
47. Initiation of warfarin is associated with decreased mortality in patients with infective endocarditis: a population based cohort study
48. Impact of proton pump inhibitor on quality of anticoagulant control and outcomes in atrial fibrillation patients treated with an oral anticoagulant in the COOL-AF registry
49. Mortality prediction in patient with atrial fibrillation and 0 or 1 nongender-related CHA2DS2-Vasc risk factor using machine learning: a French nationwide study
50. Impact of chronic obstructive pulmonary disease on the natural history of atrial fibrillation: a report from the GLORIA-AF registry phase II & III
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.